CVS Health reports Q3 earnings, opioid settlement


Rafael Henrique | Lightrocket | Getty Images

CVS Health reported third quarter earnings Wednesday morning that beat Wall Street’s expectations. 

Here’s how the pharmacy giant performed compared to Wall analysts’ estimates, according to Refinitiv:

  • Earnings per share $2.09 vs. $1.99, expected.
  • Revenue $81.16 billion vs. $76.75 billion, expected.

It’s the third consecutive quarter in which CVS beat earnings expectations. Revenue rose 10% year-over-year.

CVS’ Health Care Benefits segment grew nearly 10% compared to the same quarter last year, driven in part by an increase in its medical memberships from 2021. Pharmacy services revenue increased over 10% compared to the period last year, as total…

Source cnbc.com

0 0 votes
Article Rating

What the Fed’s fourth 0.75 percentage point rate hikes means for you

Previous article

Mortgage demand falls even as rates slip from recent highs

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings